A pharmaceutical company developing drugs for neurological and autoimmune/metabolic diseases
Nov 17, 2021
Pharmasum Therapeutics announces the publication of an article titled “Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome” in the journal Pharmaceuticals. READ MORE >>
Nov 11, 2021
Pharmasum Therapeutics has been selected to present at the DNB healthcare conference December 16, 2021 READ MORE >>
Nov 2, 2021
Pharmasum Therapeutics announces that the Company has moved into offices at the Oslo Science Park. READ MORE >>